ArticleAnnals of the rheumatic diseases2020
Abstract readComment
In one paragraph
Article in Annals of the rheumatic diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.Arthritis & rheumatology (Hoboken, N.J.) · 2021Pooled it
- The role of Pannexin-1 channels, ATP, and purinergic receptors in the pathogenesis of HIV and SARS-CoV-2.Current opinion in pharmacology · 2023Review
- Interactions between carbon nanotubes and external structures of SARS-CoV-2 using molecular docking and molecular dynamics.Journal of molecular structure · 2023Article
- Fast Methods for Drug Approval: Research Perspectives for Pandemic Preparedness.International journal of environmental research and public health · 2023Article
- Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by SingerAnnals of the rheumatic diseases · 2022Article
- Response to: 'Correspondence on 'Annals of the rheumatic diseases · 2022Article
- Frequency, characteristics and outcome of corona virus disease 2019 (COVID-19) infection in Iranian patients with rheumatic diseases.The Egyptian rheumatologist · 2022Article
- Medication of Hydroxychloroquine, Remdesivir and Convalescent Plasma during the COVID-19 Pandemic in Germany-An Ethical Analysis.International journal of environmental research and public health · 2021Article
- Response to: 'COVID-19 in patients with rheumatological diseases treated with Anti-TNF' by BritoAnnals of the rheumatic diseases · 2021Article
- Global research collaboration in a pandemic-challenges and opportunities: the COVID-19 Global Rheumatology Alliance.Current opinion in rheumatology · 2021Review
- Tocilizumab for Severe COVID-19 Pneumonia: Experience from 5 Geriatric Chinese Patients with 6 Months Follow-up.Rheumatology and immunology research · 2021Article
- The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study.Clinical rheumatology · 2020Article
- Impact of Chronic Use of Antimalarials on SARS-CoV-2 Infection in Patients With Immune-Mediated Rheumatic Diseases: Protocol for a Multicentric Observational Cohort Study.JMIR research protocols · 2020Article
- MDA5 should be detected in severe COVID-19 patients.Medical hypotheses · 2020Article
- Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'.Annals of the rheumatic diseases · 2020Article
- COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases · 2020Article
- Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.Clinical rheumatology · 2020Observational
- Conducting research in a pandemic: The power of social media.European journal of rheumatology · 2020Article
- The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey.Rheumatology international · 2020Article
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.Annals of the rheumatic diseases · 2020Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Comment on
Authors and funding
20 authors.
Elizabeth R Graef *Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Jean W Liew *Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, United States.
Michael S PutmanDepartment of Medicine, Division of Rheumatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.ORCID 0000-0001-9699-4000
Julia F SimardHealth Research & Policy, Division of Epidemiology and Department of Medicine, Division of Immunology & Rheumatology, Stanford School of Medicine, Stanford, California, USA.
Emily SirotichMcMaster University, Hamilton, Ontario, Canada.
Francis BerenbaumDepartment of Rheumatology, Sorbonne Université, Paris, France.ORCID 0000-0001-8252-7815
Alí Duarte-GarcíaDivision of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
Rebecca GraingerMalaghan Institute of Medical Research, Wellington, New Zealand.
Carly HarrisonLupusChat, New York, New York, USA.
Maximilian F KonigDivision of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Peter KorstenDepartment of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany.ORCID 0000-0001-6065-5680
Laurie ProulxCanadian Arthritis Patient Alliance, Ottawa, Ontario, Canada.
Dawn P RichardsCanadian Arthritis Patient Alliance, Ottawa, Ontario, Canada.
Philip C RobinsonPrincess Alexandra Hospital, Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia.
Sebastian E SattuiDivision of Rheumatology, Hospital for Special Surgery, New York, New York, USA.ORCID 0000-0002-3945-6828
Manuel Francisco Ugarte-GilUniversidad Cientifica del Sur, Lima, Peru.ORCID 0000-0003-1728-1999
Kristen J YoungUniversity of Texas Southwestern Medical School, Dallas, Texas, USA.
Alfred Hj Kim *Division of Rheumatology, Department of Medicine, Washington University School of Medicine in St. Louis, Saint Louis, Missouri, USA jsparks@bwh.harvard.edu akim@wustl.edu.ORCID 0000-0003-4074-0516
Jeffrey A Sparks *Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA jsparks@bwh.harvard.edu akim@wustl.edu.ORCID 0000-0002-5556-4618
COVID-19 Global Rheumatology Alliance
Funding
Joint Biology Consortium Resource-based CenterP30AR070253 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter A Nigrovic, Jeffrey Andrew Sparks · 2016 to 2026
$9.4MWashington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI Christine T. Pham · 2018 to 2026
$7.6MMultidisciplinary Rheumatology Training ProgramT32AR048522 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI CLIFTON O BINGHAM, LIVIA A CASCIOLA-ROSEN · 2003 to 2026
$6.4MRheumatoid Arthritis and Respiratory Outcomes in Prospective CohortsK23AR069688 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SPARKS, JEFFREY ANDREW · 2016 to 2020
$766kRespiratory Diseases, Genetics, and Rheumatoid Arthritis RiskR03AR075886 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SPARKS, JEFFREY ANDREW · 2019 to 2020
$179kNIAMS NIH HHS K23 AR069688NIAMS NIH HHS L30 AR066953NIAMS NIH HHS L30 AR072421NIAMS NIH HHS P30 AR073752NIAMS NIH HHS R03 AR075886NIAMS NIH HHS T32 AR048522
Abstract
PubMed holds no abstract for this paper.
Indexed as
HydroxychloroquineRheumatologistsAzithromycinBetacoronavirusCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralSARS-CoV-2AzithromycinHydroxychloroquineantirheumatic agentshealth services researchhydroxychloroquine
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.